Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
May 1, 2018
Multiple sclerosis (MS) is an immune-mediated infammatory disease in which the immune system progressively destroys its own myelinated axons in the central
nervous system, in episodes lasting from a few months to many years in duration. Te eventual demyelination and axonal degeneration can cause serious and debilitating motor, sensory, balance and cognitive problems, disability, serious complications, and negatively impact quality of life.